Medication info

Donggu Memantine Hydrochloride Tablet 10 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 202000106 · Approved 2020.01.07

This product's status changed to Expired on 2025.01.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1~7): Administer 5mg daily for 7 days. Week 2 (Days 8~14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15~21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Elderly patients: Based on clinical data, the recommended dose for patients 65 years of age and older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Because there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1~7): Administer 5mg daily for 7 days. Week 2 (Days 8~14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15~21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Elderly patients: Based on clinical data, the recommended dose for patients 65 years of age and older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Because there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be used in patients who are hypersensitive to any of its components or have severe liver or kidney impairment. Use with caution in patients with epilepsy, a history of seizures, or a predisposition to seizures. Avoid concomitant use with NMDA receptor antagonists such as amantadine, ketamine, or dextromethorphan as side effects may increase or persist. Dietary changes that may alter urinary acidity or patients with certain urinary infections should be monitored closely. Caution is needed in patients with recent myocardial infarction, congestive heart failure, or uncontrolled hypertension due to insufficient safety data. During treatment, side effects such as dizziness, headache, constipation, drowsiness, or hypertension may occur; consult a physician if any symptoms arise. Psychiatric side effects such as confusion, hallucinations, and psychotic reactions may rarely occur, and any abnormal symptoms should be reported immediately. This medication may interact with other drugs, particularly NMDA antagonists, antipsychotics, skeletal muscle relaxants, and anticoagulants; use with caution under medical guidance. Pregnant women or women who may become pregnant should consult a physician before use, as this medication may affect the fetus, and breastfeeding should be discontinued if using this medication. Safety and efficacy in children and adolescents under 18 years have not been established, and use is not recommended. In case of overdose, symptoms such as confusion, drowsiness, dizziness, hallucinations, seizures, and vomiting may occur; seek immediate medical treatment. This medication may affect the central nervous system, so caution is needed when driving or operating machinery. Finally, this medication should be stored out of reach of children, and transferring to other containers should be avoided as it can adversely affect product quality.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity
  • confusion
  • hallucination
  • psychotic reaction
Show 28 more
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • venous thrombosis
  • thromboembolism
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • abnormal psychosis
  • depression
  • suicidal thoughts
  • suicide
  • feelings of fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • coma
  • double vision
  • restlessness
  • psychosis
  • visual hallucinations
  • stupor
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture, and it is safe to store it at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.